Benjamin H. Lowentritt, MD, FACS


EP. 3A: Financial Perspectives on the Use of Leuprolide Formulations in Prostate Cancer

August 23, 2022

In the third interview of the series, Benjamin H. Lowentritt, MD, FACS, reflects on financial and operational considerations in the use of leuprolide with emphasis on managing the cost burden, coding and reimbursement, and product inventory.